Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, December 25, 2024 in observance of Christmas and Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Disease Surveillance: Preventing the New Pandemic

Disease Surveillance: Peventing the New pandemic

Click here to listen

EPISODE SUMMARY

Welcome to Season 2 of Diagnostic Dialogues - Innovation & Insight, where we are covering the hottest topics in healthcare with top researchers, doctors, and thought leaders!

Today, host Dr Pat Alagia is joined by Dr Hema Kapoor and Dr Robert Jones to discuss disease surveillance! The trio talk about why COVID took the world by surprise and what they have learned about preventative measures and testing in order to better prepare for future pandemics like Monkeypox. Plus, the doctors speak about surveillance as the key to identifying novel viruses and address privacy concerns in regards to data collection. Hit play and enjoy this episode of Diagnostic Dialogues - Innovation & Insight from Quest Diagnostics.

Date: September 12, 2022

Podcast contributors

  • Dr. Pat Alagia
  • Dr. Hema Kapoor
  • Dr. Robert Jones

Follow Us

Presented by Quest Diagnostics
www.questdiagnostics.com

Related content

Audio Podcast
COVID-19: Supporting Safety for the Front Line
Publication
Comparison of SARS-CoV-2 RT-PCR Ct values across multiple assays with different targets
Publication
Identification of Human Mpox Virus Genome Deletions That Impact Diagnostic Assays
Conference Presentation
Performance of a dual target mpox virus real-time PCR assay

Related content

Publication
New Cancer Diagnoses Still Lagging in the United States in Second Full Year of COVID-19 Pandemic
Publication
Comparison of SARS-CoV-2 RT-PCR Ct values across multiple assays with different targets
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes
Conference Presentation
Performance of a dual target mpox virus real-time PCR assay
Test FAQ
SARS CoV 2 Antibody Testing
Test FAQ
Mpox Virus DNA, Qualitative Real-Time PCR

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.